Effects of strontium-modified titanium surfaces on adhesion,
migration and proliferation of bone marrow mesenchymal stem cells and
expression of bone formation-related genes

doi:10.3969/j.issn.2095-4344.2022

Abstract

Abstract:

BACKGROUND: Strontium promotes bone formation, and reduces bone resorption. Strontium-modified titanium implant surface has been the focus of research in implant osseointegration under osteoporotic conditions.

OBJECTIVE: To investigate the cell adhesion, stretch, and migration of advanced strontium-modified titanium surfaces using bone marrow mesenchymal stem cells isolated from rats.

METHODS: Strontium-modified titanium surfaces were produced by sequential treatments with 5 mol/L NaOH, 100 mmol/L strontium acetate, and heated at 600 or 700 °C for 1 hour. After heat treatment, half the samples were soaked in deionized water at 80 °C for 24 hours, then washed and dried. The pure titanium served as control group, and there were five groups. The whole bone marrow adherence method was used to separate bone marrow mesenchymal stem cells from the rats. The modified titanium sheets were placed in 24-well plates and cultured in cell suspension. Cell adhesion and cell proliferation were assessed using cell counting kit-8 assay. After bone marrow mesenchymal stem cells were with the titanium sheet for 24 hours, the actin was stained to observe cell adhesion and stretch. The migration of bone marrow mesenchymal stem cells on different titanium surfaces was investigated using cell scratch test and fluorescence staining. The expression levels of collagen type І, Runx2, osteoprotegerin, RANKL and osteopontin were detected by qRT-PCR.

RESULTS AND CONCLUSION: Strontium-modified titanium could promote the stretch and migration of bone marrow mesenchymal stem cells. The number of proliferative cells in the Sr700 group was significantly higher than that in the Sr600 group at 5 days (P < 0.01). On day 14, strontium-modified titanium promoted the expression of collagen type І, Runx2, and osteopontin. In summary, strontium-modified titanium can promote adhesion, spreading, migration and proliferation of rat bone marrow mesenchymal stem cells. Moreover, hydration treatment can enhance the osteogenic activity of rat bone marrow mesenchymal stem cells.

Key words: pure titanium, strontium-modified, bone marrow mesenchymal stem cells, cell adhesion, cell proliferation, bone formation-related genes

CLC Number:

Liu Chundong, Shen Xiaoqing, Zhang Yanli, Zhang Xiaogen, Wu Buling. Effects of strontium-modified titanium surfaces on adhesion, migration and proliferation of bone marrow mesenchymal stem cells and expression of bone formation-related genes[J]. Chinese Journal of Tissue Engineering Research, 2020, 24(7): 1009-1015.

Figures/Tables 6

References

[1] RACHNER TD, KHOSLA S, HOFBAUER LC. Osteoporosis: now and the future. Lancet. 2011;377(9773):1276-1287.
[2] RADI IA, IBRAHIM W, ISKANDAR SMS, et al. Prognosis of dental implants in patients with low bone density: A systematic review and meta-analysis. J Prosthet Dent. 2018;120(5): 668-677.
[3] TEMMERMAN A, RASMUSSON L, KÜBLER A, et al. A Prospective, Controlled, Multicenter Study to Evaluate the Clinical Outcome of Implant Treatment in Women with Osteoporosis/Osteopenia: 5-Year Results. J Dent Res. 2019; 98(1):84-90.
[4] YIN G, LIU H, LI J, et al. Adenoviral delivery of adiponectin ameliorates osteogenesis around implants in ovariectomized rats. J Gene Med. 2019;21(2-3):e3069.
[5] DEREKA X, CALCIOLARI E, DONOS N, et al. Osseointegration in osteoporotic-like condition: A systematic review of preclinical studies. J Periodontal Res. 2018;53(6): 933-940.
[6] GRISA A, VEITZ-KEENAN A. Is osteoporosis a risk factor for implant survival or failure. Evid Based Dent. 2018;19(2): 51-52.
[7] 周延民,汪汉池,赵静辉,等.种植体表面改性效果的研究[J].口腔医学研究,2018,34(4):343-346.
[8] PILMANE M, SALMA-ANCANE K, LOCA D, et al. Strontium and strontium ranelate: Historical review of some of their functions. Mater Sci Eng C Mater Biol Appl. 2017;78: 1222-1230.
[9] SCARDUELI CR, BIZELLI-SILVEIRA C, MARCANTONIO RAC, et al. Systemic administration of strontium ranelate to enhance the osseointegration of implants: systematic review of animal studies. Int J Implant Dent. 2018;4(1):21.
[10] OFFERMANNS V, ANDERSEN OZ, RIEDE G, et al. Effect of strontium surface-functionalized implants on early and late osseointegration: A histological, spectrometric and tomographic evaluation. Acta Biomater. 2018;69:385-394.
[11] ROMERO-GAVILÁN F, ARAÚJO-GOMES N, GARCÍA-ARNÁEZ I, et al. The effect of strontium incorporation into sol-gel biomaterials on their protein adsorption and cell interactions. Colloids Surf B Biointerfaces. 2019;174:9-16.
[12] CHEN X, CHEN Y, SHEN J, et al. Positive modulation of osteogenesis on a titanium oxide surface incorporating strontium oxide: An in vitro and in vivo study. Mater Sci Eng C Mater Biol Appl. 2019;99:710-718.
[13] LIU C, ZHANG Y, WANG L, et al. A Strontium-Modified Titanium Surface Produced by a New Method and Its Biocompatibility In Vitro. PLoS One. 2015;10(11):e0140669.
[14] ZHOU C, XU AT, WANG DD, et al. The effects of Sr-incorporated micro/nano rough titanium surface on rBMSC migration and osteogenic differentiation for rapid osteointegration. Biomater Sci. 2018;6(7):1946-1961.
[15] POLISETTI N, CHAITANYA VG, BABU PP, et al. Isolation, characterization and differentiation potential of rat bone marrow stromal cells. Neurol India. 2010;58(2):201-208.
[16] INSUA A, MONJE A, WANG HL, et al. Basis of bone metabolism around dental implants during osseointegration and peri-implant bone loss. J Biomed Mater Res A. 2017; 105(7):2075-2089.
[17] OFFERMANNS V, ANDERSEN OZ, SILLASSEN M, et al. A comparative in vivo study of strontium-functionalized and SLActive™ implant surfaces in early bone healing. Int J Nanomedicine. 2018;13:2189-2197.
[18] LIU F, LI Y, LIANG J, et al. Effects of micro/nano strontium-loaded surface implants on osseointegration in ovariectomized sheep. Clin Implant Dent Relat Res. 2019; 21(2):377-385.
[19] IBRAHIM M, SCHOELERMANN J, MUSTAFA K, et al. TiO2 nanoparticles disrupt cell adhesion and the architecture of cytoskeletal networks of human osteoblast-like cells in a size dependent manner. J Biomed Mater Res A. 2018;106(10): 2582-2593.
[20] FU DL, JIANG QH, HE FM, et al. Adhesion of bone marrow mesenchymal stem cells on porous titanium surfaces with strontium-doped hydroxyapatite coating. J Zhejiang Univ Sci B. 2017; 18(9): 778-788.
[21] MULLEN CA, VAUGHAN TJ, VOISIN MC, et al. Cell morphology and focal adhesion location alters internal cell stress. J R Soc Interface. 2014;11(101):20140885.
[22] ZHAO L, WANG H, HUO K, et al. The osteogenic activity of strontium loaded titania nanotube arrays on titanium substrates. Biomaterials. 2013;34(1):19-29.
[23] HANDSCHIN AE, EGERMANN M, TRENTZ O, et al. Cbfa-1 (Runx-2) and osteocalcin expression by human osteoblasts in heparin osteoporosis in vitro. Clin Appl Thromb Hemost. 2006; 12(4):465-472.
[24] LIAN JB, JAVED A, ZAIDI SK, et al. Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors. Crit Rev Eukaryot Gene Expr. 2004;14(1-2):1-41.
[25] HU D, LI K, XIE Y, et al. The combined effects of nanotopography and Sr ion for enhanced osteogenic activity of bone marrow mesenchymal stem cells (BMSCs). J Biomater Appl. 2017;31(8):1135-1147.
[26] KNIGHT CG, MORTON LF, ONLEY DJ, et al. Identification in collagen type I of an integrin alpha2 beta1-binding site containing an essential GER sequence. J Biol Chem. 1998; 273(50):33287-33294.
[27] DRIVER J, WEBER CE, CALLACI JJ, et al. Alcohol inhibits osteopontin-dependent transforming growth factor-β1 expression in human mesenchymal stem cells. J Biol Chem. 2015;290(16):9959-9973.
[28] REICHERT JC, QUENT VM, BURKE LJ, et al. Mineralized human primary osteoblast matrices as a model system to analyse interactions of prostate cancer cells with the bone microenvironment. Biomaterials. 2010;31(31):7928-7936.
[29] LIU L, LUO Q, SUN J, et al. Cytoskeletal control of nuclear morphology and stiffness are required for OPN-induced bone-marrow-derived mesenchymal stem cell migration. Biochem Cell Biol. 2019;97(4):463-470.
[30] GENG Z, WANG X, ZHAO J, et al. The synergistic effect of strontium-substituted hydroxyapatite and microRNA-21 on improving bone remodeling and osseointegration. Biomater Sci. 2018;6(10):2694-2703.
[31] MI B, XIONG W, XU N, et al. Strontium-loaded titania nanotube arrays repress osteoclast differentiation through multiple signalling pathways: In vitro and in vivo studies. Sci Rep. 2017;7(1):2328.
[32] LU X, ZHANG W, LIU Z, et al. Application of a Strontium-Loaded, Phase-Transited Lysozyme Coating to a Titanium Surface to Enhance Osteogenesis and Osteoimmunomodulation. Med Sci Monit. 2019;25: 2658-2671.
[33] YASUDA H, SHIMA N, NAKAGAWA N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A. 1998;95(7):3597-3602.
[34] LI CW, LIANG B, SHI XL, et al. Opg/Rankl mRNA dynamic expression in the bone tissue of ovariectomized rats with osteoporosis. Genet Mol Res. 2015;14(3):9215-9224.